容百科技(688005.SH):全固態電池用超高鎳正極材料已得到多家海內外客户的認證
格隆匯3月31日丨容百科技(688005.SH)在互動平台表示,2024年,公司9系以上超高鎳產品銷售超2.7萬噸,公司的高鎳及超高鎳系列產品技術與生產規模均處於全球領先地位。9系超高鎳三元正極材料是固態電池未來的主要方向,公司在固態電池領域持續投入,其中,半固態電池用超高鎳正極材料保持穩定出貨,全固態電池用超高鎳正極材料已得到多家海內外客户的認證,其容量與循環性能保持行業領先。未來隨着麒麟電池、大圓柱電池、固態電池等高能量密度電池的需求提升,以及人形機器人、低空經濟、無人機等新興細分領域崛起,公司9系超高鎳三元材料產品的出貨量有望進一步增加。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.